Many funding organisations have recently announced new calls for funding for the spring. We want to guide you through the jungle and have curated a list for researchers at K2. But there and there are more calls at the homepage of the research advisors at the Faculty: Application Support for External Funding | Faculty of Medicine | UiB.
If you plan to apply for funding, we appreciate if you inform the Department via this form:: Varsel om søknad om ekstern finansiering / Intention to apply for external funding (uib.no). Happy Grant Writing!
Meltzer fond
150.000 NOK, for UiB employees. Travel, running costs, organising conferences etc.
Deadline: annual, next: 12 January 2024
ERA4Health Modulation of brain ageing through nutrition and healthy lifestyle (NutriBrain)
Transnational calls with 3-5 partners, 36 months. Funding: 300.000 EUR for the Norwegian participants (400.000 for coordinators). The other partners receive funding from their national funders. On the improvement of cognitive brain ageing through nutrition and other lifestyle factors.
Deadline (pre proposals): 15 January 2024
Novo Nordisk Endocrinology and Metabolism
– Excellence Emerging Investigator Grant Endocrinology and Metabolism
10 MIO DKK, 5 years. For researchers at 4-8 years after PhD.
–Ascending Investigator Grant. 5 years, 10 MIO DKK. For researcher 7-18 years after PhD. Prevention of disease relevant to the human organism within the areas of endocrinology and metabolism, relating to cellular energy homeostasis, and hormonal disorders of the endocrine system.
– Distinguished Investigator Grant. 5 years 10 MIO DKK.
Deadline: 16 January 2024
ERA4Health Nano and advanced technologies for disease prevention, diagnostic and therapy (NANOTECMEC)
3-5 partners, 3 countries, 3 MNOK for the Norwegian participant. Regenerative medicine, Diagnostics or Nanotherapy. TRL3-6. The aim of the call is to advance nanomedicine toward any translational focus with anticipated impact relative to the risk and investment.
Deadline (pre proposals): 30 January 2024
Global Initiative on Chronic Diseases / NIH Primary and Secondary Prevention of Cancer
Budget not limited, 5 years. Implementation research in Low- and Middle-Income Countries or in populations facing conditions of vulnerability in High-Income Countries.
Deadline: 05 February 2024
DAM Foundation Research grants (Forskning)
1,5-3 MIO NOK for 3 years. Stiftelsen Dam is one of Norway’s largest foundations and provides funding for health and research projects that will provide better health through participation and activity for people in Norway. The applications are sent through a volunteer oganisation like the Norwegian Red Cross, The Norwegian Cancer Society, the National Association for Publich Health etc.
Deadline: annually, 15 February
ERA PerMed PMTargets
Joint Transnational Call, most likely 3-5 partners from at least 3 countries, 300.000 EUR for the Norwegian partners. Topic: Identification or Validation of Targets for Personalised Medicine Approaches. Must combine the research on new and advanced targets with companion biomarker research (companion diagnostics).
Deadline: 5 March 2024
NFR Collaborative Projects Food-Climate-Health
12 MIO NOK, 4 years. Requires collaboration with partners in other sectors.
The projects must be interdisciplinary and cross-sectoral. They must include elements from each of these three areas and look at the relationships and interaction effects between them:
– food (sea and/or land-based)
– environment and/or climate
– public health
Deadline: 13 March 2024
NFR Collaborative Projects Enabling Technologies
12 MIO NOK, 4 years. Requires collaboration with partners in other sectors.
– Industrial Biotechnology. Biotechnological methods, enzymes, microorganisms and other cell systems to produce various products, such as pharmaceuticals, chemicals, feed, textiles and energy.
– Technology convergence. Create radically new technologies through professional fusion within the enabling technologies.
Deadline: 13 March 2024
JPIAMR AMR Interventions 2024
3-7 Partners from 3 countries. Probably 300.000 EUR for the Norwegian partners; other partners are funded by their national funders.
Topic 1: Design novel or improved interventions to prevent, mitigate and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance
Topic 2: Improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.
Deadline (preproposals): 14 March 2024
HKDir UTFORSK
3 MNOK, 4 years. The Norwegian Directorate for Higher education and skills finances these educational projects with Brazil, Canada, China, India, Japan, South Africa, South Korea, or the USA.
Deadline: 15 April 2024
Innovative Health Initiative Call 6 and 7
The Innovative Health Initiative (IHI) is a public-private partnership between the European Union and the European life science industries that funds health research and innovation to address unmet public health needs and foster interdisciplinary and international collaboration. Upcoming topics:
– 6.1: Support healthcare system resilience through a focus on persistency in the treatment of chronic diseases. 60 months. The pre-defined industry consortium will contribute 11 MIO EUR. IHI will contribute 11 MIO EUR. This budget is expected to cover four pilots in different disease areas (including diabetes, obesity, and cardiovascular disease) in different geographies and healthcare systems.
– 6.2: Development of practical guidance and recommendations for using real world data/real world evidence in healthcare decision-making. 60 montsh. Pre-defined industry consortium will contribute 13 MIO EUR. IHI contributes 13 MIO EUR.
– 7.1 Improving clinical management of heart disease from early detection to treatment. 12,5 MIO EUR.
– 7.2 User-centric technologies and optimised hospital workflows for a sustainable healthcare workforce. 12,5 MIO EUR
– 7.3 Clinical validation of biomarkers for diagnosis, monitoring disease progression and treatment response. 15 MIO EUR.
Deadline: summer 2024
